Follow-up of COLL2-1, COLL2-1NO2 and myeloperoxydase in dogs after transection of the cruciate ligament of the knee

Poster (2009, May 23)

Purpose: To determine the profile of Coll2-1, Coll2-1NO2 and myeloperoxydase (MPO) serum concentrations in experimental knee OA induced in the dog by transection of the anterior cruciate ligament. Methods ... [more ▼]

Purpose: To determine the profile of Coll2-1, Coll2-1NO2 and myeloperoxydase (MPO) serum concentrations in experimental knee OA induced in the dog by transection of the anterior cruciate ligament. Methods: Surgical transection of the ACL of the right knee was performed on 16 adult crossbred dogs. The dogs were sacrificed 8 weeks after the surgical procedure. Coll2-1, Coll2-1NO2 and MPO were measured by specific immunoassays in 16 dogs at baseline and every 2 weeks during the 8 weeks. The results were expressed as median (range). Results: Immunostainings with D3 and D37, the antiserum recognizing Coll2-1 and Coll2-1NO2, respectively, labelled extracellular matrix in the superficial layer of fibrillated cartilage. After the transection of the ACL, the concentration of 3 biomarkers increased significantly (Friedman test: p<0.001). The concentrations of Coll2-1 and MPO were significantly increased at week 2 compared to baseline [Coll2-1 baseline: 281.57 (131.02-384.67) nM vs Coll2-1 week 2: 345.52 (181.15-589.25) nM (p<0.01) and MPO baseline: 5.16 (<0.4-14.7) ng/ml vs MPO week 2: 14.54 (3.28-31.50) ng/ml (p<0.001)] and remained stable until week 8 [Coll2-1 week 8:318.89 (117.95-492.28) nM and MPO week 8: 11.55 (2.87-42.94) ng/ml]. The Coll2-1NO2 concentration increased significantly at weeks 6 and 8 compared to baseline [Coll2-1NO2 baseline: 0.54 (0.29-1.48) nM vs Coll2-1NO2 week 6: 0.64 (0.40-1.9) nM (p<0.001) vs week 8: 0.61 (0.37-1.79) nM]. Conclusions: These findings suggest that Coll2-1 is a relevant marker for the detection of early structural changes in OA dogs. Interestingly, MPO and Coll2-1NO2 are increased in OA dogs indicating that an oxidative stress occurs in this OA model. [less ▲]

One-Year Follow-up of Coll2-1, Coll2-1no2 and Myeloperoxydase Serum Levels in Osteoarthritis Patients after Hip or Knee Replacement

in Annals of the Rheumatic Diseases (2008), 67(2), 168-74

OBJECTIVES: To determine Coll2-1, Coll2-1NO(2) and myeloperoxydase (MPO) levels in serum of patients with knee or hip osteoarthritis (OA) before the surgery, 3 months and 1 year after knee or hip ... [more ▼]

OBJECTIVES: To determine Coll2-1, Coll2-1NO(2) and myeloperoxydase (MPO) levels in serum of patients with knee or hip osteoarthritis (OA) before the surgery, 3 months and 1 year after knee or hip replacement. METHODS: Coll2-1, Coll2-1NO(2) and MPO were measured in 103 patients with isolated symptomatic knee or hip OA candidates for joint replacement. Sera were taken the day before surgery, 3 months and 1 year after hip or knee replacement. Coll2-1 and Coll2-1NO(2) immunohistochemistry was performed on biopsies removed from cartilage lesions. RESULTS: Immunostainings revealed the extensive presence of Coll2-1 and Coll2-1NO(2) in the superficial layer of fibrillated cartilage and around some chondrocytes clusters. Three months after joint replacement, Coll2-1 and MPO serum levels were decreased and even reached the reference value for Coll2-1. By contrast, Coll2-1NO(2) levels remained elevated. At 1-year follow-up, Coll2-1 levels remained at the reference value, MPO levels were similar to those measured at 3 months, and Coll2-1NO(2) levels were unchanged and comparable to the pre-surgery values. However, in patients with pre-surgery values above the median (more than 0.42 nM), Coll2-1NO(2) levels significantly and progressively decreased post-operatively, but tended towards an increase in patients with pre-surgery Coll2-1NO(2) values below the median. CONCLUSIONS: The normalisation of Coll2-1 levels 3 months after surgery indicates that Coll2-1 is a disease-specific marker that is sensitive to the structural changes occurring in a single joint. Furthermore, the immunohistochemical findings are consistent with the concept that the major source of serum Coll2-1 is the damaged articular cartilage. Finally, serum MPO levels decreased after joint replacement indicating that neutrophil activation occurs in OA joints, even in the late stage of the disease. [less ▲]

Follow-up of COLL2-1, COLL2-1NO2 and myeloperoxidase serum levels in marathon runners

in Osteoarthritis and Cartilage (2007), 15(Suppl C), 67

One year follow-up of COLL 2-1, COLL 2-1 NO2 and myeloperoxydase serum levels in osteoarthritic patients after hip or knee replacement

in Osteoarthritis and Cartilage (2006), 14(Suppl B), 18